Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyridoxine-responsive PH1: treatment

C Toussaint1

  • 1Département médico-chirurgical de Néphrologie, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Belgium.

Journal of Nephrology
|May 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Outcomes of Direct Challenge in Adults With a History of Childhood Penicillin Allergy: A Multicenter Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Anifrolumab for refractory cutaneous manifestations of amyopathic dermatomyositis.

Annales de dermatologie et de venereologie·2026
Same author

Real-life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Endoscopic features, pathological correlates and possible origin of foveolar gastric metaplasia presenting as a duodenal polyp.

Acta gastro-enterologica Belgica·2019
Same author

[Rehabilitation standards for follow-up treatment and rehabilitation of patients with ventricular assist device (VAD)].

Clinical research in cardiology supplements·2016
Same author

[Assessment of the check-list in the operating room: perceptions of caregivers and physicians (level II assessment)].

Annales francaises d'anesthesie et de reanimation·2013

Pyridoxine therapy for primary hyperoxaluria (PH) shows limited efficacy, with half of patients unresponsive. While some see reduced oxaluria, high doses risk sensory neuropathy.

Area of Science:

  • Nephrology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Primary hyperoxaluria (PH) is a rare metabolic disorder.
  • Limited data exists on pyridoxine treatment efficacy due to PH rarity.

Purpose of the Study:

  • To evaluate the efficacy of pyridoxine therapy in patients with primary hyperoxaluria.
  • To assess the impact of pyridoxine on oxaluria levels and kidney function.

Main Methods:

  • Analysis of two recent reports involving 18 PH patients treated with pyridoxine.
  • Review of reported outcomes on patient response, oxaluria normalization, and kidney function.

Main Results:

  • 50% of patients were unresponsive to pyridoxine therapy.

Related Experiment Videos

  • 20% of patients achieved normalized oxaluria.
  • 30% of patients showed a partial reduction in oxaluria.
  • Anecdotal cases suggest potential improvement in renal function in some patients.

    • Conclusions:

    • Pyridoxine therapy demonstrates variable and often limited efficacy in primary hyperoxaluria.
    • High-dose pyridoxine (0.5-6 g/day) is associated with a risk of severe sensory neuropathy.